{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hyperventilation : Questions médicales les plus fréquentes",
"headline": "Hyperventilation : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hyperventilation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-06",
"dateModified": "2025-03-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hyperventilation"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Signes et symptômes respiratoires",
"url": "https://questionsmedicales.fr/mesh/D012818",
"about": {
"@type": "MedicalCondition",
"name": "Signes et symptômes respiratoires",
"code": {
"@type": "MedicalCode",
"code": "D012818",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.852"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hyperventilation",
"alternateName": "Hyperventilation",
"code": {
"@type": "MedicalCode",
"code": "D006985",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Naoto Fujii",
"url": "https://questionsmedicales.fr/author/Naoto%20Fujii",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Health and Sport Sciences, University of Tsukuba , Tsukuba , Japan."
}
},
{
"@type": "Person",
"name": "Takeshi Nishiyasu",
"url": "https://questionsmedicales.fr/author/Takeshi%20Nishiyasu",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Health and Sport Sciences, University of Tsukuba , Tsukuba , Japan."
}
},
{
"@type": "Person",
"name": "Eun Hye Oh",
"url": "https://questionsmedicales.fr/author/Eun%20Hye%20Oh",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Pusan National University School of Medicine, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea."
}
},
{
"@type": "Person",
"name": "Seo Young Choi",
"url": "https://questionsmedicales.fr/author/Seo%20Young%20Choi",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea."
}
},
{
"@type": "Person",
"name": "Thomas Ritz",
"url": "https://questionsmedicales.fr/author/Thomas%20Ritz",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study.",
"datePublished": "2023-03-31",
"url": "https://questionsmedicales.fr/article/37002313",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-32356-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Synchronous fluorescence as a green and selective method for the simultaneous determination of finasteride and tadalafil in dosage form and spiked human plasma.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37187147",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.saa.2023.122838"
}
},
{
"@type": "ScholarlyArticle",
"name": "Approaches for estimating the clinical starting dose of new dosage forms: An example of a long-acting injectable formulation of finasteride.",
"datePublished": "2022-12-19",
"url": "https://questionsmedicales.fr/article/36549406",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2022.122510"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluating the combined efficacy of oral isotretinoin and topical tacrolimus versus oral finasteride and topical tacrolimus in frontal fibrosing alopecia-A randomized controlled trial.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35815916",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jocd.15232"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Comparative Effects of Monotherapy with Topical Minoxidil, Oral Finasteride, and Topical Finasteride in Postmenopausal Women with Pattern Hair Loss: A Retrospective Cohort Study.",
"datePublished": "2024-04-29",
"url": "https://questionsmedicales.fr/article/39108554",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000538621"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Signes et symptômes respiratoires",
"item": "https://questionsmedicales.fr/mesh/D012818"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hyperventilation",
"item": "https://questionsmedicales.fr/mesh/D006985"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hyperventilation - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hyperventilation",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hyperventilation",
"description": "Comment diagnostiquer l'hyperventilation ?\nQuels tests sont utilisés pour l'hyperventilation ?\nL'hyperventilation peut-elle être confondue avec d'autres conditions ?\nQuels signes cliniques indiquent l'hyperventilation ?\nL'hyperventilation est-elle mesurable ?",
"url": "https://questionsmedicales.fr/mesh/D006985?mesh_terms=Finasteride&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hyperventilation",
"description": "Quels sont les symptômes courants de l'hyperventilation ?\nL'hyperventilation provoque-t-elle des douleurs thoraciques ?\nPeut-on ressentir de l'anxiété avec l'hyperventilation ?\nL'hyperventilation entraîne-t-elle une fatigue ?\nLes symptômes de l'hyperventilation sont-ils permanents ?",
"url": "https://questionsmedicales.fr/mesh/D006985?mesh_terms=Finasteride&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hyperventilation",
"description": "Comment prévenir l'hyperventilation ?\nLes exercices de respiration aident-ils à prévenir l'hyperventilation ?\nL'éducation sur l'anxiété peut-elle prévenir l'hyperventilation ?\nLe yoga peut-il aider à prévenir l'hyperventilation ?\nLes techniques de méditation sont-elles utiles ?",
"url": "https://questionsmedicales.fr/mesh/D006985?mesh_terms=Finasteride&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hyperventilation",
"description": "Quels traitements sont disponibles pour l'hyperventilation ?\nComment la thérapie comportementale aide-t-elle ?\nLes médicaments sont-ils nécessaires pour l'hyperventilation ?\nQuelles techniques de respiration sont recommandées ?\nL'hyperventilation nécessite-t-elle une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D006985?mesh_terms=Finasteride&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hyperventilation",
"description": "Quelles complications peuvent survenir avec l'hyperventilation ?\nL'hyperventilation peut-elle causer des évanouissements ?\nDes troubles cardiaques peuvent-ils être liés à l'hyperventilation ?\nL'hyperventilation peut-elle affecter la santé mentale ?\nY a-t-il des risques à long terme liés à l'hyperventilation ?",
"url": "https://questionsmedicales.fr/mesh/D006985?mesh_terms=Finasteride&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hyperventilation",
"description": "Quels sont les facteurs de risque de l'hyperventilation ?\nL'anxiété est-elle un facteur de risque ?\nLes athlètes sont-ils plus à risque d'hyperventilation ?\nLes maladies pulmonaires augmentent-elles le risque ?\nLe tabagisme est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006985?mesh_terms=Finasteride&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperventilation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'évaluation des symptômes respiratoires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'hyperventilation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de gaz du sang peuvent être effectués pour évaluer les niveaux de CO2."
}
},
{
"@type": "Question",
"name": "L'hyperventilation peut-elle être confondue avec d'autres conditions ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec l'anxiété ou des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent l'hyperventilation ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des palpitations, des étourdissements et des picotements peuvent indiquer l'hyperventilation."
}
},
{
"@type": "Question",
"name": "L'hyperventilation est-elle mesurable ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être mesurée par la fréquence respiratoire et les niveaux de CO2 dans le sang."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'hyperventilation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des vertiges, des palpitations, et des sensations de picotement."
}
},
{
"@type": "Question",
"name": "L'hyperventilation provoque-t-elle des douleurs thoraciques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des douleurs thoraciques dues à une tension musculaire."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir de l'anxiété avec l'hyperventilation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hyperventilation peut être à la fois un symptôme et un déclencheur d'anxiété."
}
},
{
"@type": "Question",
"name": "L'hyperventilation entraîne-t-elle une fatigue ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue peut survenir en raison d'une respiration inefficace et d'une hyperoxie."
}
},
{
"@type": "Question",
"name": "Les symptômes de l'hyperventilation sont-ils permanents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes sont généralement temporaires et liés à des épisodes de stress ou d'anxiété."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperventilation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par la gestion du stress, des techniques de relaxation et une respiration consciente."
}
},
{
"@type": "Question",
"name": "Les exercices de respiration aident-ils à prévenir l'hyperventilation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des exercices réguliers de respiration peuvent aider à stabiliser le rythme respiratoire."
}
},
{
"@type": "Question",
"name": "L'éducation sur l'anxiété peut-elle prévenir l'hyperventilation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre l'anxiété et ses effets peut réduire les épisodes d'hyperventilation."
}
},
{
"@type": "Question",
"name": "Le yoga peut-il aider à prévenir l'hyperventilation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le yoga favorise la relaxation et améliore la conscience respiratoire."
}
},
{
"@type": "Question",
"name": "Les techniques de méditation sont-elles utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la méditation aide à réduire le stress et à réguler la respiration."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'hyperventilation ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des techniques de respiration, la thérapie cognitivo-comportementale et des médicaments."
}
},
{
"@type": "Question",
"name": "Comment la thérapie comportementale aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à gérer l'anxiété et à modifier les comportements de respiration inappropriés."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils nécessaires pour l'hyperventilation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais des anxiolytiques peuvent être prescrits si l'anxiété est sévère."
}
},
{
"@type": "Question",
"name": "Quelles techniques de respiration sont recommandées ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la respiration diaphragmatique et la respiration lente sont recommandées."
}
},
{
"@type": "Question",
"name": "L'hyperventilation nécessite-t-elle une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, sauf en cas de complications graves ou de crises d'anxiété sévères."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'hyperventilation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles électrolytiques, des spasmes musculaires et des évanouissements."
}
},
{
"@type": "Question",
"name": "L'hyperventilation peut-elle causer des évanouissements ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hyperventilation sévère peut entraîner des évanouissements en raison d'une hypoxie."
}
},
{
"@type": "Question",
"name": "Des troubles cardiaques peuvent-ils être liés à l'hyperventilation ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hyperventilation peut provoquer des palpitations et des douleurs thoraciques, mais rarement des troubles cardiaques graves."
}
},
{
"@type": "Question",
"name": "L'hyperventilation peut-elle affecter la santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut exacerber l'anxiété et mener à des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques à long terme liés à l'hyperventilation ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des risques à long terme incluent des problèmes respiratoires chroniques et des troubles anxieux."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'hyperventilation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le stress, l'anxiété, les troubles respiratoires et certaines conditions médicales."
}
},
{
"@type": "Question",
"name": "L'anxiété est-elle un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété est un facteur majeur qui peut déclencher des épisodes d'hyperventilation."
}
},
{
"@type": "Question",
"name": "Les athlètes sont-ils plus à risque d'hyperventilation ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les athlètes peuvent hyperventiler lors d'efforts intenses ou de stress compétitif."
}
},
{
"@type": "Question",
"name": "Les maladies pulmonaires augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'asthme ou la BPCO peuvent augmenter le risque d'hyperventilation."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut aggraver les problèmes respiratoires et augmenter le risque d'hyperventilation."
}
}
]
}
]
}
Finasteride, a 5α-reductase inhibitor used in benign prostatic hyperplasia and androgenetic alopecia, has been associated with an increased suicidal risk, whereas it is unclear whether such risk is si...
Finasteride and tadalafil are combined in a pharmaceutical capsules called Entadfi™, that has received FAD approval. It was indicated for the management of male benign prostatic hyperplasia-related ur...
In our previous study, a long-acting injectable (LAI) formulation of finasteride was prepared as a new dosage form of PROPECIA®, and in vivo pharmacokinetics (PKs)-pharmacodynamics (PDs) was evaluated...
Treatment of frontal fibrosing alopecia (FFA) is complicated and challenging. In this study, we evaluated the efficacy of combining topical tacrolimus with isotretinoin versus finasteride in patients ...
Thirty-one patients with FFA were divided randomly into two groups. Therapeutic regimen of the first group (group A, n = 16) was isotretinoin and tacrolimus (Capsule isotretinoin 20 mg daily and topic...
Physician Global Assessment (PGA) was significantly better in the group A as compared with the group B at 4 weeks (p = 0.038). Physician satisfaction in the group A was better than the group B at 12 w...
Although both therapeutic regimens were effective in the treatment of FFA, treatment with tacrolimus and isotretinoin is significantly more effective than tacrolimus and finasteride....
Oral finasteride and topical minoxidil are long-standing androgenetic alopecia (AGA) treatments; topical finasteride is a more recent medicine. Few studies have compared their therapeutic effects in p...
We conducted Bayesian network meta-analyses of individual patient-level data insofar as four clinically relevant endpoints, namely, 12-month change in (1) total hair density, (2) hair diameter, (3) cl...
As per SUCRA, the most and least effective regimens - across the four outcomes - were oral finasteride, and topical finasteride, respectively; however, no significant statistical differences were foun...
Oral finasteride is ranked more effective than the topical forms of minoxidil and finasteride; however, more studies are needed to confirm this result....
A 76-year-old male developed a maculopapular rash on his trunk and extremities. The rash appeared 2 months after Finasteride administration for his prostatic hyperplasia. Clinical suspicion was of dru...
Finasteride and dutasteride, synthetic 5α-reductase inhibitors (5ARIs) are recommended in many guidelines for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms and alopecia de...
Alopecia, a widespread issue affecting both genders, often manifests as androgenetic alopecia, although a thorough examination is needed to rule out other causes. This chapter focuses on the treatment...
Male lower urinary tract symptoms have been correlated with an increased risk of death; however, it is unclear if treatment will reduce this risk. Our objective was to determine whether a reduction in...
We conducted a secondary analysis of the MTOPS (Medical Treatment of Prostate Symptoms) randomized trial of placebo, doxazosin, finasteride, or doxazosin and finasteride. Men in the United States betw...
A total of 3,046 men (median age 62, quartiles 57-68) were randomized and had a baseline AUA Symptom Score. For each 1-point improvement in the AUA Symptom Score, the hazard ratio for death was 0.96 (...
Improvement in male lower urinary tract symptoms was associated with a reduced risk of death. Further study is warranted to determine if the male treatment paradigm should shift toward symptom treatme...
To develop a novel predictive model for identifying patients who will and will not respond to the medical management of benign prostatic hyperplasia (BPH)....
Using data from the Medical Therapy of Prostatic Symptoms (MTOPS) study, several models were constructed using an initial data set of 2172 patients with BPH who were treated with doxazosin (Group 1), ...
For the entire cohort, the AUC for the boosted SVM model was 0.698. For patients in Group 1, the AUC was 0.729, for Group 2, the AUC was 0.719, and for Group 3, the AUC was 0.698....
Using MTOPS data, we were able to develop a prediction model with an acceptable rate of discrimination of medical management success for BPH....